Japan Medical Dynamic Marketing, INC.
7600・Prime Market・Precision Instruments
Japan Segment
Parent company segment responsible for domestic sales of orthopedic medical devices
| Period | Current | Previous | Change |
|---|---|---|---|
| Net sales (external customers) | ¥13,110 million | ¥13,634 million | ↓ |
| Operating income | ¥718 million | ¥795 million | ↓ |
| Segment assets | ¥18,750 million | ¥17,954 million | ↑ |
| Depreciation | ¥694 million | ¥755 million | ↓ |
| Increase in property, plant and equipment and intangible assets | ¥362 million | ¥547 million | ↓ |
Business Details
NIPPON MDM CO., LTD. (parent company) purchases artificial joints, bone fixation materials, spinal fixation devices, and other products from its US subsidiary ODEV and domestic and overseas manufacturers, and sells them to medical institutions in Japan. The company views the expansion of orthopedic demand accompanying the aging society as a growth opportunity and promotes continuous introduction of new products and expansion of case acquisitions. The segment has a structure in which the impact of the media coverage incident, including deferred adoption decisions and intensifying competition, affects profitability.
Recent Overview
Sales declined mainly in artificial joints due to the impact of the media coverage incident, and operating income also decreased 9.6% year on year
Japan Segment net sales for FY2026 (ending March 2026) were ¥13,110 million (down 3.8% year on year), and operating income was ¥718 million (down 9.6% year on year). Due to the impact of the media coverage incident, case acquisitions decreased from the second quarter onward, with a particularly large decline in the artificial joint field (domestic ¥4,904 million, down 6.4% year on year). While wage increases were implemented, cost control efforts resulted in selling, general and administrative expenses falling below the previous year in total.
Key Products
Growth Drivers
- Continued expansion of demand for orthopedic surgery accompanying the aging society
- Acquisition of new facilities and increased case acquisitions through continuous introduction of new products
- Expansion of the Balloon Kyphoplasty market centered on the KMC Kyphoplasty system (achieved double-digit growth in the current period)
- Underpinning of the bone fixation materials field through steady case volume trends for Prima Hip Screw
- Improved profitability through promotion of cost containment measures
Risks
- Continued risk of deferred adoption at medical institutions due to the series of media coverage incidents in Japan
- Continued reduction in reimbursement prices due to healthcare fee schedule revisions (structure in which price pass-through is difficult)
- Slowing growth rate due to intensifying competitive environment (in the bone fixation materials field, among others)
- Upward pressure on the SG&A expense ratio due to increased personnel costs from wage increases
- Impact of decreased sales from discontinued products resulting from product portfolio review
Last updated: June 18, 2026